Join Free
SI Premium
RSS Feeds
E-mail Alerts
Portfolio
Login
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Novo Nordisk A/S ADR
(NY:
NVO
)
131.83
-1.45 (-1.09%)
Streaming Delayed Price
Updated: 12:52 PM EDT, Jul 24, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
1,126,709
Open
132.50
Bid (Size)
131.84 (1)
Ask (Size)
131.86 (1)
Prev. Close
133.28
Today's Range
130.92 - 132.90
52wk Range
77.95 - 148.15
Shares Outstanding
N/A
Dividend Yield
1.34%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Novo Nordisk's Stock Dips In Pre-Market Despite Winning UK's Approval Of Weight Loss Drug: What's Going On
Today 6:57 EDT
Wegovy, a GLP-1 receptor agonist, had previously been approved for use in obesity treatment and weight management.
Via
Benzinga
3 Stocks to Buy if There Is No Interest Rate Cut This Year
Today 6:15 EDT
Here are three stocks to buy and hold for steady gains if the Federal Reserve decides against an interest rate cut in 2024.
Via
InvestorPlace
Topics
Economy
Exposures
Interest Rates
Performance
YTD
+29.11%
+29.11%
1 Month
-7.34%
-7.34%
3 Month
+2.48%
+2.48%
6 Month
+25.11%
+25.11%
1 Year
+62.68%
+62.68%
More News
Read More
Insulin Device Maker Embecta Weighs Sale After 70% Share Decline Following Becton Dickinson Spin-Off
July 23, 2024
Via
Benzinga
Britain's Drug Regulator Approves Novo Nordisk's Weight Loss Drug Wegovy To Cut Heart Disease Risk In Obese Patients
July 23, 2024
Via
Benzinga
Look Out, Eli Lilly and Novo Nordisk: Could Roche Be the Obesity Drug Stock to Really Watch?
July 23, 2024
Via
The Motley Fool
Novo Nordisk Options Trading: A Deep Dive into Market Sentiment
July 19, 2024
Via
Benzinga
Why Hims & Hers Heath Shares Are Surging Today
July 22, 2024
Via
Benzinga
Biden's Exit From Presidential Race 'Yet Another Curveball For Equity Investors': Analysts
July 22, 2024
Via
Benzinga
Oral Weight Loss Drugs Vs. Injections - Pills Are Promising Yet Challenging Frontier
July 22, 2024
Via
Benzinga
7 Sorry Biotech Stocks Set to Make Investors Sad
July 22, 2024
Via
InvestorPlace
Here's My Top Growth Stock to Buy Right Now
July 20, 2024
Via
The Motley Fool
3 Monster Stocks in the Making to Buy Right Now
July 20, 2024
Via
The Motley Fool
Craze For Ozempic And Zepbound For Weight Loss Leave Diabetic Patients Without Critical GLP-1 Medications
July 19, 2024
Via
Benzinga
Stock Market Rotation Gets Rough; ASML, Eli Lilly, CrowdStrike, UnitedHealth In Focus: Weekly Review
July 19, 2024
Via
Investor's Business Daily
Eli Lilly's Famed Weight Loss Drug Zepbound Scores Chinese Approval
July 19, 2024
Via
Benzinga
7 A-Rated Stock Picks With Huge Upside Potential
July 19, 2024
Via
InvestorPlace
Is Viking Therapeutics a Millionaire-Maker?
July 19, 2024
Via
The Motley Fool
EXCLUSIVE: Weight-Loss Duopoly Breaks As Eli Lilly, Novo Plummet; 'Market Won't Be Dominated By Just 2 Players'
July 18, 2024
Via
Benzinga
VIX Stages Double-Digit Spike As Risk Off Takes Over; Chipmakers Fail To Rebound, Weight Loss Giants Eli Lilly, Novo Tumble: What's Driving Markets Thursday?
July 18, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
AI Demand and New Deals Make Ginkgo Bioworks Stock a Speculative Buy
July 18, 2024
Via
InvestorPlace
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Forget Boring Diversification! 3 Wild-Card Stocks to Spice Up Your Portfolio
July 17, 2024
Via
InvestorPlace
Novo Nordisk Faces Setback in Netherlands Over Wegovy Insurance Coverage
July 17, 2024
Via
Benzinga
Why Roche Stock Just Popped, but Eli Lilly and Novo Nordisk Dropped
July 17, 2024
Via
The Motley Fool
Pfizer And Roche Advance On Their Weight Loss Drug Journeys
July 17, 2024
Via
Benzinga
Obesity-Drugs Focused Stocks Tumble On Wednesday - What's Going On With Eli Lilly, Novo Nordisk, Viking Therapeutics, Structure Therapeutics?
July 17, 2024
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.